Cancer Research Funding to Improve the Lives of Patients
September 5, 2013

The Ontario Institute for Cancer Research has pledged $52 million in funding to support translational research that aims to improve the entire spectrum of cancer care, from prevention and early diagnosis, to diagnosis and treatment.

Successfully funded projects include Dr. Robert Rottapel's "Innovation in Target Validation Program", which will use high-throughput technologies to streamline the identification of cancer targets, particularly those for ovarian cancer.  Also funded is Dr. John Dick's "Cancer Cell Program" for the use of cutting-edge technology to identify and characterize cancer stem cells, which are thought to be responsible for initiating and maintaining cancer.  

These projects have the potential to improve cancer diagnosis, to address the resistance of cancers to therapy and to develop more effective, personalized cancer therapies.
You have an old version of Adobe's Flash Player. Get the latest Flash player.